Identification of the optimal patients for trifluridine/tipiracil (FTD/TPI) treatment in mCRC: A Spanish real-world analysis.

Ana Montes,Francisca Vázquez Rivera,Nieves Martínez Lago,Marta Covela Rúa,Antia Cousillas Castineiras,Paula González Villarroel,Juan De la Cámara,Carlos Méndez Méndez,Mercedes Salgado Fernández,Sonia Candamio Folgar,Margarita Reboredo López,Marta Carmona Campos,Elena Gallardo Martin,Mónica Jorge Fernández,María Luz Pellón-Augusto,Jesús García Gómez

Identification of the optimal patients for trifluridine/tipiracil (FTD/TPI) treatment in mCRC: A Spanish real-world analysis.

2020

Ana Montes
Francisca Vázquez Rivera
Nieves Martínez Lago
Marta Covela Rúa
Antia Cousillas Castineiras
Paula González Villarroel
Juan De la Cámara
Carlos Méndez Méndez
Mercedes Salgado Fernández
Sonia Candamio Folgar
Margarita Reboredo López
Marta Carmona Campos
Elena Gallardo Martin
Mónica Jorge Fernández
María Luz Pellón-Augusto
Jesús García Gómez

146Background: FTD/TPI has demonstrated significantly overall survival (OS) and progression-free survival (PFS) in patients (pts) with metastatic colorectal cancer (mCRC) refractory to standard the...

Keywords:

Internal medicine
Physical therapy
Oncology
Medicine
in patient
Refractory
Colorectal cancer
overall survival
Pathology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations